ARCHIVES

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

This article is from The Cancer Letter archive.

Vol. 34 No. 19 | May 16, 2008

Download PDF Visit The Full Archive

Related Articles

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

NCI Staff Phone Numbers Listed

September 14, 1979

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001